KRAS and neoplasm: As previously reported, the majority of these alterations were located at the hotspot codon 12, the spectrum was concordant with the distribution of KRAS tumor mutation types from ICGC data [34–36], suggesting that KRAS mutations in the circulating DNA mainly originate from tumor cells.